Pfizer and GlaxoSmithKline Announce Joint Venture to Create a …
WEBPfizer Inc. (NYSE: PFE) and GlaxoSmithKline plc (NYSE:GSK) today announced they have entered into an agreement to create a premier global consumer healthcare company with robust iconic brands.
Pfizer Announces Closing of Joint Venture With GlaxoSmithKline …
WEBAug 1, 2019 · Pfizer Inc. (NYSE: PFE) today announced the closing of its joint venture with GlaxoSmithKline plc (NYSE: GSK) to combine the parties’ respective consumer healthcare businesses to create the world’s largest over-the-counter (OTC) business with robust iconic brands.
Pfizer to exit GSK consumer health joint venture after London …
WEBJun 1, 2022 · Pfizer will sell down its stake in Haleon, its consumer health joint venture with GlaxoSmithKline, after a London listing planned for July 18.
GSK completes transaction with Pfizer to form new world-leading ...
WEBGSK today announced that it has completed its transaction with Pfizer to combine their consumer healthcare businesses into a Joint Venture.
GlaxoSmithKline plc and Pfizer Inc to form new world-leading Consumer …
WEBDec 19, 2018 · GSK and Pfizer have today entered into an agreement under which, upon closing of the proposed transaction, Pfizer will contribute its consumer healthcare business to GSK’s existing consumer healthcare business in return for equity shares in this business.
Update - GSK Consumer Healthcare | GSK US
WEBJan 15, 2022 · The Consumer Healthcare business is a Joint Venture between GSK and Pfizer, with GSK holding a majority controlling interest of 68% and Pfizer 32%. GSK rejected all three proposals made on the basis that they fundamentally undervalued the Consumer Healthcare business and its future prospects.
Update - GSK Consumer Healthcare
WEBJan 15, 2022 · The Consumer Healthcare business is a Joint Venture between GSK and Pfizer, with GSK holding a majority controlling interest of 68% and Pfizer 32%. GSK rejected all three proposals made on the basis that they fundamentally undervalued the Consumer Healthcare business and its future prospects.
Pfizer to sell stake in GSK's consumer health business after it lists
WEBLONDON, June 1 (Reuters) - Pfizer (PFE.N) plans to sell its 32% stake in Haleon, its consumer health venture with British drugmaker GSK (GSK.L), after the business lists as an independent company...
GSK and Pfizer hold out for £60bn bid for consumer health unit
WEBJan 16, 2022 · GlaxoSmithKline and Pfizer are holding out for an improved bid of at least £60bn for their consumer healthcare joint venture, bolstered by shareholder opposition to Unilever’s £50bn offer.
Drugmaker GSK to split after striking Pfizer consumer health deal
WEBDec 19, 2018 · LONDON (Reuters) - GlaxoSmithKline plans to split into two businesses -- one for prescription drugs and vaccines, the other for over-the-counter products -- after forming a new joint venture with...
- Some results have been removed
Skip to content